GVM±R
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GVM±R, covering 2025-05-13 to 2025-05-14. Get the full timeline:
Most recent: Clinical Trial Update: GVM±R in Patients With Relapsed or Refractory Aggressive NHL. [Phase 2]